Metoprolol Tartrate Accord Healthcare (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors in the heart. This inhibition reduces heart rate, myocardial contractility, and cardiac output, leading to lower blood pressure and decreased oxygen demand by the heart muscle. The drug also diminishes renin release from the kidneys, contributing to its antihypertensive effect.

The appropriate dose of Metoprolol Tartrate Accord Healthcare is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Safety of Metoprolol Tartrate during pregnancy or lactation has not been definitively established. Healthcare providers will weigh potential benefits against possible risks before prescribing it to pregnant or nursing women. Patients should discuss any concerns with their physician before starting or continuing therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol Tartrate is a cardio‑selective (β1‑selective) blocker, offering a lower risk of bronchospasm compared with non‑selective agents such as propranolol. Its relatively short half‑life allows flexible dosing, but may require multiple daily doses. Clinicians choose it when selective β1 blockade is desired, especially in patients with respiratory concerns.

Metoprolol Tartrate Accord Healthcare should be stored at ambient temperature below 25 °C. Keep the tablets in the original container, protect them from moisture, heat and direct sunlight, and ensure the packaging remains tightly closed until use.

Metoprolol Tartrate is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the specific instructions given by their prescriber to maintain consistent blood levels and therapeutic effect.

Serious risks include marked bradycardia, symptomatic hypotension, atrioventricular block, and bronchospasm in patients with reactive airway disease. Rarely, severe allergic reactions such as anaphylaxis can occur. Patients should seek immediate medical attention if they experience fainting, severe dizziness, difficulty breathing, or swelling of the face or throat.

Metoprolol Tartrate should be avoided in individuals with known hypersensitivity to the drug, severe bradycardia, second‑ or third‑degree AV block without a pacemaker, decompensated heart failure, or uncontrolled asthma/COPD. Clinicians must assess each patient’s medical history before initiating therapy.